Northwest Biotherapeutics
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Purchase
COGNATE BIOSERVICES, INC. 10 percent owner
Warrants 132,500 $0.4 $53,000
Purchase
TOUCAN PARTNERS, LLC 10 percent owner
Amended and Restated Warrants 76,250,000 N/A N/A
Purchase
TOUCAN PARTNERS, LLC 10 percent owner
Amended and Restated Warrant 2,500,000 N/A N/A
Purchase
TOUCAN PARTNERS, LLC 10 percent owner
Warrants 18,125,000 N/A N/A
Purchase
TOUCAN PARTNERS, LLC 10 percent owner
Series A Preferred Stock Warrant 19,500,000 N/A N/A
Purchase
TOUCAN PARTNERS, LLC 10 percent owner
Series A-1 Preferred Stock Warrant 3,408,833 N/A N/A
Purchase
POWERS LINDA F director, 10 percent owner, off..
Warrant 4,000,000 N/A N/A
Purchase
TOUCAN CAPITAL FUND II, LP 10 percent owner
Warrant 5,000,000 $495,000 $2,475,000,000,000
Purchase
TOUCAN CAPITAL FUND II, LP 10 percent owner
Warrant 5,000,000 $495,000 $2,475,000,000,000
Purchase
TOUCAN CAPITAL FUND II, LP 10 percent owner
Warrant 5,000,000 N/A N/A
Purchase
TOUCAN CAPITAL FUND II, LP 10 percent owner
Warrant 4,500,000 $445,500 $2,004,750,000,000
Purchase
TOUCAN CAPITAL FUND II, LP 10 percent owner
Warrant 4,500,000 N/A N/A
Purchase
TOUCAN CAPITAL FUND II, LP 10 percent owner
Preferred Stock Warrant 13,000,000 N/A N/A
Purchase
TOUCAN CAPITAL FUND II, LP 10 percent owner
Series A Cumulative Convertible Preferred Stock 32,500,000 $0.04 $1,300,000
Purchase
TOUCAN CAPITAL FUND II, LP 10 percent owner
Warrant 2,500,000 N/A N/A
Purchase
TOUCAN CAPITAL FUND II, LP 10 percent owner
Warrant 5,000,000 $495,000 $2,475,000,000,000
Purchase
TOUCAN CAPITAL FUND II, LP 10 percent owner
Warrant 5,000,000 $495,000 $2,475,000,000,000
Purchase
TOUCAN CAPITAL FUND II, LP 10 percent owner
Warrant 20,000,000 $1,980,000 $39,600,000,000,000
Purchase
TOUCAN CAPITAL FUND II, LP 10 percent owner
Warrant 0 $0.04 $0
Sale
NORTHWEST HOSPITAL 10 percent owner
Common Stock 14,565 $0.25 $3,641
Sale
NORTHWEST HOSPITAL 10 percent owner
Common Stock 14,565 $0.25 $3,641
Sale
NORTHWEST HOSPITAL 10 percent owner
Common Stock 14,565 $0.25 $3,641
Sale
NORTHWEST HOSPITAL 10 percent owner
Common Stock 14,565 $0.25 $3,641
Sale
NORTHWEST HOSPITAL 10 percent owner
Common Stock 14,565 $0.25 $3,641
Sale
NORTHWEST HOSPITAL 10 percent owner
Common Stock 14,565 $0.25 $3,641
Sale
NORTHWEST HOSPITAL 10 percent owner
Common Stock 14,565 $0.25 $3,641
Sale
NORTHWEST HOSPITAL 10 percent owner
Common Stock 14,565 $0.25 $3,641
Sale
NORTHWEST HOSPITAL 10 percent owner
Common Stock 14,565 $0.25 $3,641
Sale
NORTHWEST HOSPITAL 10 percent owner
Common Stock 14,565 $0.25 $3,641
Sale
NORTHWEST HOSPITAL 10 percent owner
Common Stock 14,565 $0.25 $3,641
Sale
NORTHWEST HOSPITAL 10 percent owner
Common Stock 14,565 $0.25 $3,641
Sale
NORTHWEST HOSPITAL 10 percent owner
Common Stock 14,565 $0.25 $3,641
Sale
NORTHWEST HOSPITAL 10 percent owner
Common Stock 14,565 $0.25 $3,641
Sale
NORTHWEST HOSPITAL 10 percent owner
Common Stock 14,565 $0.25 $3,641
Sale
NORTHWEST HOSPITAL 10 percent owner
Common Stock 14,565 $0.25 $3,641
Sale
NORTHWEST HOSPITAL 10 percent owner
Common Stock 14,565 $0.25 $3,641
Sale
NORTHWEST HOSPITAL 10 percent owner
Common Stock 14,565 $0.25 $3,641
Sale
NORTHWEST HOSPITAL 10 percent owner
Common Stock 14,565 $0.25 $3,641
Sale
NORTHWEST HOSPITAL 10 percent owner
Common Stock 14,565 $0.25 $3,641
Sale
NORTHWEST HOSPITAL 10 percent owner
Common Stock 14,565 $0.25 $3,641

Showing 100 to 140 of 140 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.